ReviewClinical and molecular hepatology2025

Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations.

Pojsakorn Danpanichkul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.